Capstone Investment Advisors, LLC Aclaris Therapeutics, Inc. Transaction History
Capstone Investment Advisors, LLC
- $35.4 Billion
- Q1 2025
A detailed history of Capstone Investment Advisors, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 23,564 shares of ACRS stock, worth $36,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,564Holding current value
$36,995% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ACRS
# of Institutions
117Shares Held
93.9MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$22.4 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$15.1 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$14 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$7.92 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$7.8 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $105M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...